Exact Mass: 876.3991

Exact Mass Matches: 876.3991

Found 36 metabolites which its exact mass value is equals to given mass value 876.3991, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Glucoconvallatoxoloside

4-{5-[(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl)oxy]-7,11-dihydroxy-2-(hydroxymethyl)-15-methyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl}-2,5-dihydrofuran-2-one

C41H64O20 (876.3991)


Glucoconvallatoxoloside is isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the US Isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA.

   

Met-enkephalin-Arg-Phe

2-(2-{2-[2-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}acetamido)-3-phenylpropanamido]-4-(methylsulfanyl)butanamido}-5-[(diaminomethylidene)amino]pentanamido)-3-phenylpropanoic acid

C42H56N10O9S (876.3952)


   
   

3beta,23-dihydroxyolean-12-en-28-oic acid 28-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside 3-sulfate ester

3beta,23-dihydroxyolean-12-en-28-oic acid 28-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside 3-sulfate ester

C42H68O17S (876.4177)


   

2beta-[[3-O-(3-hydroxy-1-oxo-3-phenylpropyl)-2-(3-methyl-1-oxobutyl)-4-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl]oxy]-13,15alpha-hydroxy-19-norkaur-16-ene-18-oic acid

2beta-[[3-O-(3-hydroxy-1-oxo-3-phenylpropyl)-2-(3-methyl-1-oxobutyl)-4-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl]oxy]-13,15alpha-hydroxy-19-norkaur-16-ene-18-oic acid

C45H64O17 (876.4143)


   

4-O-beta-D-callobiosyl-12beta-hydroxyfrugoside

4-O-beta-D-callobiosyl-12beta-hydroxyfrugoside

C41H64O20 (876.3991)


   

eclalbasaponin VI

eclalbasaponin VI

C42H68O17S (876.4177)


   

Konbamid|konbamide|Konbanamide

Konbamid|konbamide|Konbanamide

C40H61BrN8O9 (876.3745)


   

zygoeichwaloside K

zygoeichwaloside K

C42H68O17S (876.4177)


   

Methylen-bis-norflavaspidinsaeure|Methylenebisnorflavaspidic acid|tetra-albaspidin BBBB|tetra-albaspidin-BBBB

Methylen-bis-norflavaspidinsaeure|Methylenebisnorflavaspidic acid|tetra-albaspidin BBBB|tetra-albaspidin-BBBB

C47H56O16 (876.3568)


   

Sulfopatrinoside II

Sulfopatrinoside II

C42H68O17S (876.4177)


   

Sulfopatrinoside I

Sulfopatrinoside I

C42H68O17S (876.4177)


   

Aluminum triacetylfusarinin C [M+Al-2H]

Aluminum triacetylfusarinin C [M+Al-2H]

C39H57AlN6O15 (876.3697)


   

Glucoconvallatoxoloside

4-{5-[(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl)oxy]-7,11-dihydroxy-2-(hydroxymethyl)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}-2,5-dihydrofuran-2-one

C41H64O20 (876.3991)


   

Met-Enkephalin-Arg-Phe

Tyr-gly-gly-phe-met-arg-phe

C42H56N10O9S (876.3952)


D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004745 - Enkephalins

   

Hydrogenobyrinate(4-)

Hydrogenobyrinate(4-)

C45H56N4O14-4 (876.3793)


   

Hydrogenobyrinate a,c-diamide

Hydrogenobyrinate a,c-diamide

C45H60N6O12-2 (876.4269)


   
   
   
   

Protease-Activated Receptor-1, PAR-1 Agonist (TFA)

Protease-Activated Receptor-1, PAR-1 Agonist (TFA)

C37H59F3N10O11 (876.4317)


Protease-Activated Receptor-1, PAR-1 Agonist TFA is a selective proteinase-activated receptor1 (PAR-1) agonist peptide. Protease-Activated Receptor-1, PAR-1 Agonist TFA corresponds to PAR1 tethered ligand and which can selectively mimic theactions of thrombin via this receptor[1][2].

   

3-{[3,4-dihydroxy-5-(1-hydroxy-2-{[(2e,4z)-8-hydroxydeca-2,4-dienoyl]oxy}ethyl)oxolan-2-yl]oxy}-6-[2,4-dihydroxy-6-(hydroxymethyl)phenyl]-5-hydroxy-2-(hydroxymethyl)oxan-4-yl (2e,4e,8e,10e)-7-hydroxyhexadeca-2,4,8,10-tetraenoate

3-{[3,4-dihydroxy-5-(1-hydroxy-2-{[(2e,4z)-8-hydroxydeca-2,4-dienoyl]oxy}ethyl)oxolan-2-yl]oxy}-6-[2,4-dihydroxy-6-(hydroxymethyl)phenyl]-5-hydroxy-2-(hydroxymethyl)oxan-4-yl (2e,4e,8e,10e)-7-hydroxyhexadeca-2,4,8,10-tetraenoate

C45H64O17 (876.4143)


   

13,15-dihydroxy-7-({4-[(3-hydroxy-3-phenylpropanoyl)oxy]-6-(hydroxymethyl)-3-[(3-methylbutanoyl)oxy]-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-9-methyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

13,15-dihydroxy-7-({4-[(3-hydroxy-3-phenylpropanoyl)oxy]-6-(hydroxymethyl)-3-[(3-methylbutanoyl)oxy]-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-9-methyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C45H64O17 (876.4143)


   

2-butanoyl-6-{[3-butanoyl-5-({3-butanoyl-5-[(5-butanoyl-2,4-dihydroxy-3,3-dimethyl-6-oxocyclohexa-1,4-dien-1-yl)methyl]-2,4,6-trihydroxyphenyl}methyl)-2,4,6-trihydroxyphenyl]methyl}-3,5-dihydroxy-4,4-dimethylcyclohexa-2,5-dien-1-one

2-butanoyl-6-{[3-butanoyl-5-({3-butanoyl-5-[(5-butanoyl-2,4-dihydroxy-3,3-dimethyl-6-oxocyclohexa-1,4-dien-1-yl)methyl]-2,4,6-trihydroxyphenyl}methyl)-2,4,6-trihydroxyphenyl]methyl}-3,5-dihydroxy-4,4-dimethylcyclohexa-2,5-dien-1-one

C47H56O16 (876.3568)


   

3,23-dihydroxy-12-ursen-28-oic acid; 3β-form,28-[beta-d-glucopyranosyl-(1→6)-beta-d-glucopyranosyl] ester,23-o-sulfate

NA

C42H68O17S (876.4177)


{"Ingredient_id": "HBIN007011","Ingredient_name": "3,23-dihydroxy-12-ursen-28-oic acid; 3\u03b2-form,28-[beta-d-glucopyranosyl-(1\u21926)-beta-d-glucopyranosyl] ester,23-o-sulfate","Alias": "NA","Ingredient_formula": "C42H68O17S","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "120190-30-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8405","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1s,2s,5r,6s)-2-({[(2e)-3-[(3as,4s,5r,7as)-7a-hydroxy-5-isopropyl-3-oxo-hexahydro-2-benzofuran-4-yl]-2-(hydroxymethyl)prop-2-enoyl]oxy}methyl)-6-[(1e)-3-{[(3as,6r,7s,7as)-7-[(1e)-2-carboxy-2-(hydroxymethyl)eth-1-en-1-yl]-6-isopropyl-1-oxo-hexahydro-2-benzofuran-3a-yl]oxy}-2-(hydroxymethyl)-3-oxoprop-1-en-1-yl]-2-hydroxy-5-isopropylcyclohexane-1-carboxylic acid

(1s,2s,5r,6s)-2-({[(2e)-3-[(3as,4s,5r,7as)-7a-hydroxy-5-isopropyl-3-oxo-hexahydro-2-benzofuran-4-yl]-2-(hydroxymethyl)prop-2-enoyl]oxy}methyl)-6-[(1e)-3-{[(3as,6r,7s,7as)-7-[(1e)-2-carboxy-2-(hydroxymethyl)eth-1-en-1-yl]-6-isopropyl-1-oxo-hexahydro-2-benzofuran-3a-yl]oxy}-2-(hydroxymethyl)-3-oxoprop-1-en-1-yl]-2-hydroxy-5-isopropylcyclohexane-1-carboxylic acid

C45H64O17 (876.4143)


   

[(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxidanesulfonic acid

[(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxidanesulfonic acid

C42H68O17S (876.4177)


   

[(3s,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxidanesulfonic acid

[(3s,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxidanesulfonic acid

C42H68O17S (876.4177)


   

(2r,3r,5s,6s)-3-{[(2s,3r,4r,5s)-3,4-dihydroxy-5-(1-hydroxy-2-{[(2e,4z)-8-hydroxydeca-2,4-dienoyl]oxy}ethyl)oxolan-2-yl]oxy}-6-[2,4-dihydroxy-6-(hydroxymethyl)phenyl]-5-hydroxy-2-(hydroxymethyl)oxan-4-yl (2e,4e,8e,10e)-7-hydroxyhexadeca-2,4,8,10-tetraenoate

(2r,3r,5s,6s)-3-{[(2s,3r,4r,5s)-3,4-dihydroxy-5-(1-hydroxy-2-{[(2e,4z)-8-hydroxydeca-2,4-dienoyl]oxy}ethyl)oxolan-2-yl]oxy}-6-[2,4-dihydroxy-6-(hydroxymethyl)phenyl]-5-hydroxy-2-(hydroxymethyl)oxan-4-yl (2e,4e,8e,10e)-7-hydroxyhexadeca-2,4,8,10-tetraenoate

C45H64O17 (876.4143)


   

4-[(1r,3as,3br,5as,7s,9ar,9bs,11r,11as)-7-{[(2r,3r,4r,5s,6r)-5-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-3a,11-dihydroxy-9a-(hydroxymethyl)-11a-methyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

4-[(1r,3as,3br,5as,7s,9ar,9bs,11r,11as)-7-{[(2r,3r,4r,5s,6r)-5-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-3a,11-dihydroxy-9a-(hydroxymethyl)-11a-methyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

C41H64O20 (876.3991)


   

(4,5-dihydroxy-2-{[8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxan-3-yl)oxidanesulfonic acid

(4,5-dihydroxy-2-{[8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxan-3-yl)oxidanesulfonic acid

C42H68O17S (876.4177)


   

4-{7-[(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl)oxy]-3a,11-dihydroxy-9a-(hydroxymethyl)-11a-methyl-tetradecahydrocyclopenta[a]phenanthren-1-yl}-5h-furan-2-one

4-{7-[(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl)oxy]-3a,11-dihydroxy-9a-(hydroxymethyl)-11a-methyl-tetradecahydrocyclopenta[a]phenanthren-1-yl}-5h-furan-2-one

C41H64O20 (876.3991)


   

[4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-8a-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxidanesulfonic acid

[4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-8a-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxidanesulfonic acid

C42H68O17S (876.4177)


   

(1r,4r,5r,7r,9r,10s,13s,15r)-13,15-dihydroxy-7-{[(2s,3s,4r,5s,6s)-4-{[(3s)-3-hydroxy-3-phenylpropanoyl]oxy}-6-(hydroxymethyl)-3-[(3-methylbutanoyl)oxy]-5-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-9-methyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

(1r,4r,5r,7r,9r,10s,13s,15r)-13,15-dihydroxy-7-{[(2s,3s,4r,5s,6s)-4-{[(3s)-3-hydroxy-3-phenylpropanoyl]oxy}-6-(hydroxymethyl)-3-[(3-methylbutanoyl)oxy]-5-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-9-methyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C45H64O17 (876.4143)


   

2-({[3-(7a-hydroxy-5-isopropyl-3-oxo-hexahydro-2-benzofuran-4-yl)-2-(hydroxymethyl)prop-2-enoyl]oxy}methyl)-6-[3-({7-[2-carboxy-2-(hydroxymethyl)eth-1-en-1-yl]-6-isopropyl-1-oxo-hexahydro-2-benzofuran-3a-yl}oxy)-2-(hydroxymethyl)-3-oxoprop-1-en-1-yl]-2-hydroxy-5-isopropylcyclohexane-1-carboxylic acid

2-({[3-(7a-hydroxy-5-isopropyl-3-oxo-hexahydro-2-benzofuran-4-yl)-2-(hydroxymethyl)prop-2-enoyl]oxy}methyl)-6-[3-({7-[2-carboxy-2-(hydroxymethyl)eth-1-en-1-yl]-6-isopropyl-1-oxo-hexahydro-2-benzofuran-3a-yl}oxy)-2-(hydroxymethyl)-3-oxoprop-1-en-1-yl]-2-hydroxy-5-isopropylcyclohexane-1-carboxylic acid

C45H64O17 (876.4143)